A. T. TUĞLULAR Et Al. , "Safety Data of Lenalidomide Dexamethasone Treatment In Patients with Relapsed Refractory Multiple Myeloma in Turkey," 42. Ulusal Hematoloji Kongresi ve 11. Balkan Hematoloji Günü , Turkey, 2016
TUĞLULAR, A. T. Et Al. 2016. Safety Data of Lenalidomide Dexamethasone Treatment In Patients with Relapsed Refractory Multiple Myeloma in Turkey. 42. Ulusal Hematoloji Kongresi ve 11. Balkan Hematoloji Günü , (Turkey).
TUĞLULAR, A. T., PEHLİVAN, M., SÖNMEZ, M., sarı, i., SAYDAM, G., AYYILDIZ, M. O., ... ALİ, R.(2016). Safety Data of Lenalidomide Dexamethasone Treatment In Patients with Relapsed Refractory Multiple Myeloma in Turkey . 42. Ulusal Hematoloji Kongresi ve 11. Balkan Hematoloji Günü, Turkey
TUĞLULAR, AYŞE Et Al. "Safety Data of Lenalidomide Dexamethasone Treatment In Patients with Relapsed Refractory Multiple Myeloma in Turkey," 42. Ulusal Hematoloji Kongresi ve 11. Balkan Hematoloji Günü, Turkey, 2016
TUĞLULAR, AYŞE T. Et Al. "Safety Data of Lenalidomide Dexamethasone Treatment In Patients with Relapsed Refractory Multiple Myeloma in Turkey." 42. Ulusal Hematoloji Kongresi ve 11. Balkan Hematoloji Günü , Turkey, 2016
TUĞLULAR, A. T. Et Al. (2016) . "Safety Data of Lenalidomide Dexamethasone Treatment In Patients with Relapsed Refractory Multiple Myeloma in Turkey." 42. Ulusal Hematoloji Kongresi ve 11. Balkan Hematoloji Günü , Turkey.
@conferencepaper{conferencepaper, author={AYŞE TÜLİN TUĞLULAR Et Al. }, title={Safety Data of Lenalidomide Dexamethasone Treatment In Patients with Relapsed Refractory Multiple Myeloma in Turkey}, congress name={42. Ulusal Hematoloji Kongresi ve 11. Balkan Hematoloji Günü}, city={}, country={Turkey}, year={2016}}